Howe Jill Ann 4
4 · Lineage Cell Therapeutics, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Howe Jill Ann
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-14+1,000,000→ 1,000,000 totalExercise: $1.36Exp: 2032-11-14→ Common Shares (1,000,000 underlying)
Footnotes (1)
- [F1]This option will vest as to one quarter of the shares subject to the option on November 14, 2023, and the balance will vest in 36 successive substantially equal installments thereafter, subject to the reporting person's continuous employment.